Iterum Therapeutics
ITRM
$1.53
Share price
-0.65%
Change (1 day)
31.90%
Change (1 year)
Categories
Operating Margin for Iterum Therapeutics (ITRM)
Operating Margin as of May 2024 (TTM): -277,530.00%
According to Iterum Therapeutics's latest financial reports and stock price the company's current Operating Margin is -277,530.00%. At the end of 2019 the company had an Operating Margin of -277,529.73%.
Operating Margin history for Iterum Therapeutics from 2018 to 2019
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2019 | -277,529.73% | 3049.13% |
| 2018 | -8,812.89% | 54.58% |
| 2017 | -5,701.18% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.